Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-22

Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease [NA]

View source ↗

Summary

This clinical trial update indicates that Gore's InnAVasc Arteriovenous Graft for hemodialysis access in end-stage renal disease is currently recruiting partici…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • InnAVasc Arteriovenous Graft

Snippet

Sponsor: W.L.Gore & Associates | Conditions: End Stage Renal Disease (ESRD), Kidney Failure | NA | Status: RECRUITING